- Bestsellers
- Alcoholism
- Allergy
- Alzheimers
- Anti Fungal
- Anti Viral
- Anti-Depressants
- Anti-Inflammatory
- Antibacterial
- Antibiotics
- Antiparasitic
- Arthritis
- Asthma
- Birth Control
- Blood Pressure
- COVID-19
- Cancer
- Cardiovascular
- Cholesterol
- Diabetes
- Diuretics
- Erectile Dysfunction
- Eye Drop
- Gastro Health
- General Health
- HIV
- Hair Loss
- Hepatitis C Virus (HCV)
- Herbals
- Hormones
- Men's ED Packs
- Men's Health
- Mental Illness
- Motion Sickness
- Muscle Relaxant
- Pain Relief
- Parkinson’s Disease
- Quit Smoking
- Skin Care
- Sleeping Aids
- Veterinary Medicines
- Vitamins
- Weight Loss
- Women's Health
Generic Roflumilast
Roflumilast
| Active ingredient | Roflumilast |
|---|---|
| Mechanism of action | Phosphodiesterase-4 inhibition |
| Common dose | 50 mcg |
| What is it used for? | COPD (chronic obstructive pulmonary disease) |
| Important information on taking | Take daily at same time; do not stop without medical advice |
| Common side effects | Diarrhea, nausea, headache, cough, sinus infection |
| Serious risks | Worsening heart failure; contraindicated in severe heart failure |
| Interactions | Avoid with strong CYP3A4 inhibitors; no other PDE4 inhibitors |
| Contraindications | Hypersensitivity to Roflumilast; severe heart failure (NYHA III/IV) |
| Legal status | Prescription-only medication |
A closer look at Roflumilast and how it works
Definition, therapeutic role, and mechanism of action of Roflumilast
Roflumilast is a phosphodiesterase-4 inhibitor used as a maintenance medication for chronic obstructive pulmonary disease. It works by increasing intracellular cyclic adenosine monophosphate levels in inflammatory cells. Higher cyclic adenosine monophosphate reduces the activity of enzymes that drive airway inflammation and mucus production. By modulating these pathways, Roflumilast helps to improve lung function and lower the frequency of disease exacerbations. The drug's active moiety targets the phosphodiesterase-4 enzyme complex that normally breaks down cyclic adenosine monophosphate, thereby preserving its anti-inflammatory effect. This sustained elevation of cyclic adenosine monophosphate leads to decreased release of inflammatory mediators such as cytokines and chemokines in the airway. The overall result is a clinically meaningful reduction in exacerbation risk and symptom burden for patients with severe chronic obstructive pulmonary disease.
Pharmacological properties of Roflumilast
Roflumilast is a medication that works by blocking an enzyme called phosphodiesterase 4 in lung cells. This inhibition raises levels of cyclic amp inside the cells. Higher cyclic amp reduces the activity of inflammatory cells and decreases the release of chemicals that cause swelling. As a result the drug helps to lower airway inflammation in people with chronic obstructive pulmonary disease. It is classified as a maintenance treatment meant to improve lung function over the long term. The combined effect of these actions leads to fewer exacerbations and easier breathing for patients.
Therapeutic indications for Roflumilast
| COPD | 25 mg once daily; long-term maintenance |
|---|---|
| Asthma (adjunct) | 25 mg once daily; long-term maintenance |
| Chronic bronchitis | 25 mg once daily; long-term maintenance |
Common side effects of Roflumilast
The most common side effects
Common side effects include headache, dizziness, and fatigue. Some people also experience mild nausea or digestive discomfort. Tingling or mild skin irritation can occur in certain individuals. These reactions are usually temporary and subside without intervention. The frequency and severity can vary based on dosage and individual sensitivity. Monitoring personal response helps in understanding how the body adapts.
What to know before starting Roflumilast
The most common side effects observed across many treatments include headache. Nausea often accompanies these experiences. Fatigue can affect daily activities. Dizziness may occur unexpectedly. Mild skin irritation is another frequently noted reaction. Understanding these patterns helps in recognizing typical responses.
Common reactions associated with Roflumilast
- Headache
- Diarrhea
- Nausea
- Bronchitis
- Insomnia
- Abdominal pain
Roflumilast is an oral phosphodiesterase-4 inhibitor that can modestly reduce exacerbations in patients with severe copd who are already using long-acting bronchodilators. It works by lowering inflammation in the lungs, but its anti-inflammatory effect is milder than that of inhaled steroids, so it is best viewed as an add-on therapy rather than a replacement. Because the drug can cause diarrhea, nausea, and weight loss, it is wise to take it with food and stay hydrated while monitoring any changes in appetite. Some patients experience mood alterations or new-onset depression, so any abrupt mood changes should be reported to a clinician promptly. Smoking cessation remains the most critical step in managing copd, and Roflumilast cannot substitute for inhaled bronchodilators or rescue inhalers. If you notice persistent gastrointestinal upset or psychiatric symptoms, your doctor may adjust the dose or consider an alternative therapy. Overall, use Roflumilast as part of a comprehensive copd plan that includes medication adherence, regular monitoring, and lifestyle modifications for the best outcomes.
| Shipping method | Delivery time | Price | |
| Airmail service Delivery | 14-21 days | 10$ | Tracking# available in 4 days |
| Trackable service Delivery | 9-14 days | 30$ | Tracking# available in 2 days |
- Shipping worldwide
- Confidentiality and anonymity guarantee
- Safe and secure
- Discrete looking packages
- Dispatch orders within 24 hours
- 100% success delivery
